CTNNB1 (beta-catenin) mutations are common in endometrioid carcinomas, PICK3CA mutations are most frequent in clear cell carcinoma, and ARID1A (the AT-rich interactive domain 1A) mutations are often observed in both tumor types [146–148]. This evidence concerns the gene ARID1A and neoplasm.